Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

BRIEF Bendamustine and Rituximab In Elderly Follicular (BRIEF)

This study has been terminated.
(Treament with rituximab during maintenance phase was stoped, according to DSMC recommendations, since 3 cases of deaths occured.)
Sponsor:
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation
ClinicalTrials.gov Identifier:
NCT01313611
First received: February 21, 2011
Last updated: April 7, 2015
Last verified: April 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2017
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)